Short communication · 19 Mar 2024
Conference abstractPublished 29 Feb 2016
Pharmacological activities of 3-iodothyronamine (T1AM) and 3-iodothyroacetic acid (TA1), two among the end metabolites of Thyroid hormone
University of Florence, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
3-iodothyronamine (T1AM) is a trace amine derived from Thyroid hormone metabolism circulating in rodents and humans whose physiological role remains to be discovered. Much is instead known on T1AM pharmacological effects even if the the mechanism(s) responsible for such effects are only partially exploited. T1AM pharmacodynamics features include interaction at trace amine receptors (subtypes 1-3-8), alfa2 and b2 adrenergic receptors. Interestingly, at alfa-2 and TAAR8 the amine behaves as an inverse agonist. More recently, T1AM was reported as a modulator of TRPM8, thus suggesting T1AM as a multi-target molecule and as a possible modulator of G-protein coupled receptors. Accordingly, we have recently described T1AM as an antagonist at muscarinic type 3 receptor. In the last years we have been involved in exploiting pharmacological effects of T1AM low doses in mice. In recent years we have our results suggest T1AM has the potential to behave as a neuromediator of the histaminergic signaling. In particular we found that the amine is able to modify mice behavior including feeding, learning and memory, pain threshold. All these effects were due, at least in part, to the production of its oxidative metabolite, the TA1. Interstingly enough, the TA1/T1AM endogenous levels averaging 1.7% is maintained also after pharmacological administration of T1AM. All the effects of T1AM and of TA1so far studied are mediated by the release of histamine. Our data indicate the existence of a novel network connecting the Thyroid with histamine. Furthermore, accumulation of T1AM and/or TA1 may account for the histaminergic and antimuscarinic effects observed in Thyroid patients including itch, hyperalgesia and disturbances of sleep/arousal cycle.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 19 Mar 2024
Enhanced Spectrometry Identification of Polar Metabolites and Thyroid Hormones in Rodent Cerebrospinal Fluid
Editorial · Nov 2020
Thyroid Hormone Analogs and Metabolites: New Applications for an Old Hormone?
Editorial · 11 Feb 2018
Thyroid hormone metabolites: what does the thyroid hide?
Perspective · 8 Mar 2023
Activation of Adipose tissue thermogenesis induced by thyroid hormone (T3, T4)
More from this journal
The newest in Journal of Thyroid Disorders & Therapy.
Research article · 6 Nov 2025
Herbal Treatments for Hypothyroidism: An Evidence-Based Review
Case report · 18 Jan 2025
Teprotumumab's Efficacy for Recurrent Severe Thyroid Eye Disease Post-Tocilizumab and Steroid Therapy
Short communication · 26 Dec 2024
Thyroid Dysfunction and Its Correlation with Gut Microbiota Dysbiosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Thyroid Disorders & Therapy
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Laura Raimondi”
- BylineArticles whose byline prints “Annunzitina Laurino”

